terry moore, b.sc., m.sc., phd. (abd) · 2018. 1. 30. · terry moore, b.sc., m.sc., phd.(abd) •...

Terry Moore, B.Sc., M.Sc., PhD. (abd)

• 24 years experience of treating chronic and recurrent

pain based upon discoveries during his PhD studies at

the University of Guelph

• Terry Moore developed the MyoWorx Integrated

Treatment Program

• Moore’s clinic, MMTR Health Inc., is located in Guelph,

Ontario.

2

MMTR Health Inc.

The MyoWorx Integrated Treatment Program

is a muscle relaxation and restoration treatment based

proprietary technology initially aimed at treating patients

with chronic and recurring pain.

Today, MMTR treats many referred patients with various

other pathological conditions that have not responded to

conventional therapies.

3

The MyoWorx Treatment Program is comprised of 3 parts:

1. Individual Patient Assessment

2. Muscle Relaxation/Restoration Treatment using the

Proprietary TM20 muscle relaxation device. Data strongly

suggest it restores function to blood vessels, muscles and

nerves

3. A Tailored Exercise Program

MyoWorxTM

Integrated Treatment for Chronic and Recurring Pain

4

Detailed focused history

Examination of symptom areas

Identifies need for ancillary laboratory tests

Assessment of contributory factors

Individual Patient Assessment

5

MyoWorxTM

MyoWorxTM

Treatment Rationale

Increased tension, painful spasm, fatigue or injury of the

muscles supporting the spine can cause pressure on the spinal

nerves as well as other paraspinal tissues and structures.

As a result, one can experience:

• pain, tingling or numbness

• altered functioning of muscles

• secondary effects on organs

Unresolved, numerous muscle and joint injuries, chronic or

recurring pain and neurological and other physical symptoms

can perpetuate

6

MyoWorxTM

TM20 Device

How it works

A patented device that delivers a sequence of electrical

frequencies in a timed manner to the paraspinal structures.

Pre-clinical studies showed these frequencies can:

• Re-establish normal resting membrane potentials in the

cells of fatigued or injured muscles

• Evoke CNS activity that facilitates muscle relaxation;

long-term effect

• Produce increases in blood flow via smooth muscle

relaxation leading to restoration of oxygen and nutrient

uptake

7

Results in improvement of:

Muscle function

• Better ability to stretch and maintain optimal muscle

fiber length resulting in increased muscle strength and

endurance

Blood flow

• Breaks the cycle of vasoconstriction

• Increases vascular perfusion

Cannot be achieved by stretching and strengthening

exercises alone

MyoWorxTM

TM20 Device

8

FDA Approved as a ‘Electronic Muscle Exerciser’: April 1982

Labeling as follows:

1. Relaxation of muscle spasm

2. Prevention of retardation of tissue atrophy

3. Increasing local blood circulation

4. Muscle-re-education

5. Immediate postsurgical stimulation of calf muscles to prevent

venous thrombosis

6. Maintaining of increasing range of motion

MyoWorx TM20 Device

9

MyoWorx TM20 Device

Why is the TM20 different from?

Transcutaneous Electrical Nerve Stimulation (TENS),

Interferential Current (IFC), or Muscle Stimulation

• TENS/IFC manage pain via direct nerve stimulation

• Increase blood flow and muscle relaxation through varying

degrees of electrically-induced muscle contraction

- usually a short term effect

TM20 patented technology aims directly at reducing the

underlying muscle spasm and relieves the associated pathologies

of both neurological and micro-vasculature structures

- potentially long term sustainable results

10

Moderate home-based stretching and strengthening exercises

aimed at ‘re-educating’ the musculature

Essential to providing long-term benefit

Educates and empowers the patient to manage symptoms

• Reduces emotional impact

• Creates awareness of external factors

e.g., barometric pressure effects

MyoWorxTM

Targeted Exercise and Symptom Management Strategies

11

MyoWorxTM

Program

Clinical Data on Chronic and Recurring Pain

12

Consecutive patients treated over a 10 year period

Data analysis Group: N=518 including 32 patients with

associated anxiety and/ or depression

All patients received the MyoWorx treatment program

MMTR recorded additional outcomes to determine the

effects of the MyoWorxMuscle Relaxation/Restoration

Treatment and Targeted Exercise on associated conditions

MyoWorxTM

ProgramClinical Data on Chronic and Recurring Pain

13

Patient Characteristics

All patients presented with chronic and recurring pain many of

whom, in retrospect, had referred pain syndromes

Presentation of pain: arthritis, migraine headaches, motor

vehicle accidents, occupational origins including repetitive

strain injuries

Pain location: head, trunk and limbs

Prior therapies included: medications, nerve block, traditional

physiotherapy, TENS, acupuncture, chiropractic, and registered

massage therapy

MyoWorxTM


14

Methodology

The degree of pain in all patients was assessed using the Borg

Pain Scale (0 to 10; 10 being most severe)

Patients pain levels were recorded before and after each

treatment

Symptoms of tingling or numbness were also graded on a

similar scale

Anatomical location of pain, anaesthesia or paraesthesia were

categorized as cervical, trapezius, thoracic, lumbar and sacral

MyoWorxTM


15

Methodology (continued)

Results were grouped as percent reduction in overall pain

score:

MyoWorxTM


16

Category % Reduction in Pain Level

Poor 0-30%

Moderate 30-70%

Excellent > 70%

Pain Response by Anatomical Site

(does not include response of referred pain syndromes)

MyoWorxTM


17

Anatomical Site Percentage Sustained Reduction in Pain Score

Overall

Response

(n=518)

No Diagnosed

Psychological Disorder

(n= 486)

Associated Depression

or Anxiety Disorder

(n=32)

Cervical 76% 80% 0%

Trapezius 76% 81% 0%

Thoracic 79% 85% 0%

Lumbar 80% 85% 0%

Sacral 78% 83% 0%

Response Rates

When there was an associated referred pain syndrome (most cases),

this symptom was abolished in over 90% of instances

When the response of the associated referred pain syndrome is

included in the total response rate, the percentages of responders

increased. For example, a patient presenting with sciatica may

experience complete resolution of associated pain in the lumber,

hip, hamstring, knee and calf areas.

MyoWorxTM


18

Anatomical Site Referred

Pain Sites

Pre-

treatment

Post-

treatment

% reduction in pain

Sciatica/ Lumbar 4 1 75%

Hip 8 0 100%

Hamstring 8 0 100%

Knee 8 0 100%

Calf 8 0 100%

95% (overall)

19

2.9% 2.3% 3.4%6.9% 9.5% 5.1%

90.2% 88.0%91.6%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Total (n = 518) Male (n = 222) Female ( n = 296)

Su

cce

ssfu

l Re

cov

ery

Total Responders: Males vs. Females

Poor Moderate Excellent

20

1.9% 3.4%5.0% 7.8%

93.1%88.8%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Acute (n = 160) Chronic (n = 358)

Su

cce

ssfu

l Re

cov

ery

Total Responders: Acute vs. Chronic


21

3.3% 2.4%6.5% 7.6%

90.0% 90.0%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Prev Ther (n = 307) No Prev Ther (n=211)

Su

cce

ssfu

l Re

cov

ery

Previous vs. No Previous Therapy

Poor Moderate excellent

22

3.0% 5.0%1.1% 2.3% 0.0%

8.3%6.7%

2.5%9.2% 7.0% 0.0%

0.0%

90.2% 92.5% 89.7% 90.1%

100.0%92.7%

0%

20%

40%

60%

80%

100%

120%

Occ

(n=167)

Occ Female

(n=80)

Occ Male

(n=87)

Occ Lin

(n=128)

Occ Blount

(n=9)

Occ GGH

(n=12)

Su

cce

ssfu

l R

eco

ve

ry

Occupational Recovery


23

0% 2.2% 4.6% 2.2% 2.2%6.9%

0.0%

0% 5.60% 6.90% 7.40% 5.50%6.90% 16.7%

100%92.1%

88.5% 90.4% 92.3%86.0% 83.3%

0%

20%

40%

60%

80%

100%

120%

10-19

(n=14)

20-29

(n=89)

30-31

(n=131)

40-49

(n=135)

50-59

(n=91)

60-69

(n=29)

70+

(n = 18)

Age and Recovery


Key Findings

The MyoWorxprogram has a high success rate in

relieving acute and chronic pain of multiple origins

All age groups benefit from treatment

Outcome is not dependent on prior therapy

MyoWorxTM

Program

Clinical Results on Chronic and Recurring Pain

24

Therapy had a Major Effect on Work Disability

After treatment, absenteeism and work disability due to pain were reduced for at least 6 months

Patients with low back injuries and repetitive strain injuries:

• treated promptly were able to continue working(e.g., Carpal Tunnel Syndrome)

• if on disability were able to return to work soon after initiating therapy

In all responders the pain was durably reduced for at least 2 months

MyoWorxTM

Program

Clinical Results on Chronic and Recurring Pain

25

Unexpected Additional Benefits Observed (requiring further study)

Relief of:

• neuropathy symptoms (e.g., trigeminal neuralgia)

• Myo-fascial pain (e.g., plantar fasciitis)

Accelerated healing of wounds (e.g., diabetic foot ulcer)

Reduction of excessive urinary frequency and urgency

MyoWorxTM

Program

Clinical Data on Chronic and Recurring Pain

26

27

MyoWorx Works

terry moore, b.sc., m.sc., phd. (abd) · 2018. 1. 30. · terry moore, b.sc., m.sc., phd.(abd) •...

Documents